Pharma companies have long demonstrated that they will employ questionable marketing and sales tactics to boost sales, no matter what the impact is on patients’ health. Now Amarin, a small drug maker that sells the prescription drug Vascepa, hopes to bolster its bottom line by suing the Food and Drug Administration, claiming that the company’s […]

New data to be released this weekend should help deepen the understanding of how broadly new drugs that unleash the body’s immune system to fight cancer can be used. Results from key clinical trials will be presented starting Friday in Chicago at the annual meeting of the American Society of Clinical Oncology. These will include […]

May 28, 2015By Aja Frost for Many employees don’t have the luxury of choosing exciting jobs. They pick their position or workplace based on more quotidian concerns: paying their bills, getting a stable job and receiving good benefits. But the awesome part about working in biotech? You can get all those perks and have […]

Deep Understanding of Physicians’ Educational Needs and Preferences Drives the Company’s Evolution   NEW YORK, May 27, 2015 — Professional Television Network, LLC today announced that it is officially changing its name to Healthcasts, LLC, to better reflect its ongoing evolution as a highly personalized, interactive educational platform for healthcare professionals, with information physicians desire, […]

At its Annual Stockholders’ Meeting held in Cologne, Germany, Bayer AG (BAYZF) laid out its plans for corporate restructuring. Marjin Dekkers, chairman of the board, discussed four strategic priorities.   #1. Focus on driving organic growth of HealthCare and CropScience. The company plans to invest more than 4 billion euros in research and development this […]

Novartis Presents New Data On 21 Medicines And 11 Investigational Compounds At ASCO And EHA   Overall survival data for Tafinlar® and Mekinist® combination to be presented in metastatic BRAF V600E/K mutation-positive cutaneous melanoma New data for Zykadia® in ALK+ non-small cell lung cancer (NSCLC) and first Phase II data for Tafinlar and Mekinist in […]

OTTAWA, May 27, 2015 /CNW/ – Export Development Canada (EDC) today announced a previously disbursed USD 67.5 M in financing for Montreal’s Valeant Pharmaceuticals International, Inc. (Valeant), Canada’s largest multinational pharmaceutical company. The loan is part of a larger USD 1 B term loan facility that Valeant is using to fund the repayment of certain outstanding […]

Opening its newest building Thursday, Genentech Inc. rolled out a bunch of facts and figures that underscore the structure’s environmental sustainability. What’s not so evident, though, is what the biotech giant’s second new structure since its 2009 takeover by Roche says about the Bay Area biotech industry. A healthy and growing Genentech injects the region’s […]

The British company that distributed and sold the drug thalidomide knew almost six months before it was pulled from the market that there were credible claims it caused terrible deformities and the deaths of infants, a new book reveals. If Distillers had heeded warnings it received in June and July 1961, as many as 1,000 […]

Biotech stocks are absolutely on fire. This is in part thanks to a growing U.S. economy and record U.S. stock market highs, since investors usually have a greater appetite for risk when the economy and stock market are on track. However, a substantial amount of credit is due to the biotech stocks themselves, which have […]